Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology Therapies
According to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...
0 Comments 0 Shares 51 Views 0 Reviews
Sponsored
MyLiveRoom https://myliveroom.com